BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 29110016)

  • 1. Allergic Contact Dermatitis Due to Ripasudil Hydrochloride Hydrate in Eye-drops: A Case Report.
    Kusakabe M; Imai Y; Natsuaki M; Yamanishi K
    Acta Derm Venereol; 2018 Feb; 98(2):278-279. PubMed ID: 29110016
    [No Abstract]   [Full Text] [Related]  

  • 2. Allergic contact dermatitis due to dorzolamide eyedrops.
    Mitsuyama S; Abe F; Higuchi T
    Contact Dermatitis; 2021 Jan; 84(1):58-59. PubMed ID: 32700819
    [No Abstract]   [Full Text] [Related]  

  • 3. Ciclosporin in parthenium dermatitis--a report of 2 cases.
    Lakshmi C; Srinivas CR; Jayaraman A
    Contact Dermatitis; 2008 Oct; 59(4):245-8. PubMed ID: 18844701
    [No Abstract]   [Full Text] [Related]  

  • 4. Allergic contact dermatitis due to ripasudil in eye drops.
    Sotozono A; Arakawa Y; Tamagawa-Mineoka R; Masuda K; Katoh N
    Contact Dermatitis; 2021 Sep; 85(3):379-380. PubMed ID: 33866572
    [No Abstract]   [Full Text] [Related]  

  • 5. Periocular allergic contact dermatitis caused by brinzolamide.
    Navarro-Triviño FJ; Ruiz-Villaverde R
    Contact Dermatitis; 2021 Apr; 84(4):274-276. PubMed ID: 33094487
    [No Abstract]   [Full Text] [Related]  

  • 6. Allergic contact dermatitis from timolol and dorzolamide eye drops.
    Kalavala M; Statham BN
    Contact Dermatitis; 2006 Jun; 54(6):345. PubMed ID: 16787459
    [No Abstract]   [Full Text] [Related]  

  • 7. Contact dermatitis by dipivefrine.
    Vilaplana J; Zaballos P; Romaguera C
    Contact Dermatitis; 2005 Mar; 52(3):169-70. PubMed ID: 15811042
    [No Abstract]   [Full Text] [Related]  

  • 8. One-Year Efficacy and Safety Assessment of Ripasudil, a Rho Kinase Inhibitor, in an Addition to or Replacing Existing Treatment Regimens: A Retrospective Study.
    Tsukahara S; Enomoto N; Ishida K; Anraku A; Tomita G
    J Ocul Pharmacol Ther; 2020 Sep; 36(7):512-521. PubMed ID: 32412867
    [No Abstract]   [Full Text] [Related]  

  • 9. Allergic contact dermatitis caused by timolol with cross-sensitivity to levobunolol.
    Horcajada-Reales C; Rodríguez-Soria VJ; Suárez-Fernández R
    Contact Dermatitis; 2015 Dec; 73(6):368-9. PubMed ID: 26227808
    [No Abstract]   [Full Text] [Related]  

  • 10. Allergic contact dermatitis caused by chromium in a mobile phone.
    Tan S; Nixon R
    Contact Dermatitis; 2011 Oct; 65(4):246-7. PubMed ID: 21906076
    [No Abstract]   [Full Text] [Related]  

  • 11. Intraocular pressure-lowering effects of ripasudil in uveitic glaucoma, exfoliation glaucoma, and steroid-induced glaucoma patients: ROCK-S, a multicentre historical cohort study.
    Futakuchi A; Morimoto T; Ikeda Y; Tanihara H; Inoue T;
    Sci Rep; 2020 Jun; 10(1):10308. PubMed ID: 32587304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allergic contact dermatitis from apraclonidine in eyedrops.
    Silvestre JF; Carnero L; Ramón R; Albares MP; Botella R
    Contact Dermatitis; 2001 Oct; 45(4):251. PubMed ID: 11683848
    [No Abstract]   [Full Text] [Related]  

  • 13. Additive intraocular pressure-lowering effects of the Rho kinase inhibitor ripasudil in Japanese patients with various subtypes of glaucoma.
    Komizo T; Ono T; Yagi A; Miyata K; Aihara M
    Jpn J Ophthalmol; 2019 Jan; 63(1):40-45. PubMed ID: 30368633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allergic contact dermatitis to phytantriol.
    Brasch J; Lipowsky F; Kreiselmaier I
    Contact Dermatitis; 2008 Oct; 59(4):251-2. PubMed ID: 18844705
    [No Abstract]   [Full Text] [Related]  

  • 15. Morphological Changes of Human Corneal Endothelial Cells after Rho-Associated Kinase Inhibitor Eye Drop (Ripasudil) Administration: A Prospective Open-Label Clinical Study.
    Nakagawa H; Koizumi N; Okumura N; Suganami H; Kinoshita S
    PLoS One; 2015; 10(9):e0136802. PubMed ID: 26367375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic contact dermatitis to dorzolamide eye drops.
    Kluger N; Guillot B; Raison-Peyron N
    Contact Dermatitis; 2008 Mar; 58(3):167-8. PubMed ID: 18279155
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy and safety of ripasudil, a Rho-associated kinase inhibitor, in eyes with uveitic glaucoma.
    Kusuhara S; Katsuyama A; Matsumiya W; Nakamura M
    Graefes Arch Clin Exp Ophthalmol; 2018 Apr; 256(4):809-814. PubMed ID: 29468405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ripasudil hydrochloride hydrate: targeting Rho kinase in the treatment of glaucoma.
    Inoue T; Tanihara H
    Expert Opin Pharmacother; 2017 Oct; 18(15):1669-1673. PubMed ID: 28893104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contact dermatitis from dipivefrine with possible cross-reaction to epinephrine.
    Parra A; Casas L; Tombo MJ; Ya nez M; Vila L
    Contact Dermatitis; 1998 Dec; 39(6):325-6. PubMed ID: 9874037
    [No Abstract]   [Full Text] [Related]  

  • 20. A case of contact dermatitis caused by timolol in anti-glaucoma eyedrops.
    Otero-Rivas MM; Ruiz-González I; Valladares-Narganes LM; Delgado-Vicente S; Rodríguez-Prieto MÁ
    Contact Dermatitis; 2015 Oct; 73(4):256-7. PubMed ID: 26094704
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.